COMMUNIQUÉS West-GlobeNewswire

Merus N.V. annonce une offre publique de souscription d’actions ordinaires
30/05/2024
UTRECHT, Pays-Bas et CAMBRIDGE, Massachusetts, 30 mai 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq : MRUS) (« Merus », la « Société », « nous » et « notre »), une société spécialisée dans l’oncologie au stade clinique [...]
Nicox annonce le lancement d’une augmentation de capital avec maintien du droit préférentiel de souscription sous forme d’ABSA d’un montant maximum d’environ 3,8 millions d’euros
30/05/2024
Communiqué de presse Nicox annonce le lancement d’une augmentation de capital avec maintien du droit préférentiel de souscription sous forme d’ABSA d’un montant maximum d’environ 3,8 millions d’euros pour poursuivre le [...]
Merus Announces Pricing of Upsized Public Offering of Common Shares
30/05/2024
UTRECHT, The Netherlands and CAMBRIDGE, Mass., May 29, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (“Merus”, the “Company,” “we” and “our”), a clinical-stage oncology company developing innovative, full-length [...]
Alterity Therapeutics to Host Webcast Today on New Data from the bioMUSE Natural History Study
30/05/2024
- New bioMUSE Data Informs ATH434-202 Study Endpoints - - Webcast to Include Key Opinion Leader, Daniel Claassen, M.D., M.S., Vanderbilt University - MELBOURNE, Australia and SAN FRANCISCO, May 29, 2024 (GLOBE NEWSWIRE [...]
Aeterna Zentaris Provides Update on Timing for Annual Meeting of Shareholders and Due Bill Redemption Date
30/05/2024
TORONTO, ONTARIO, May 29, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company developing and commercializing a diversified [...]
CloudMD Announces Resumption of Trading on TSXV and Provides Additional Transaction Details
29/05/2024
TORONTO, May 29, 2024 (GLOBE NEWSWIRE) -- CloudMD Software & Services Inc. (TSXV: DOC, Frankfurt: 6PH) (the “ Company ” or “ CloudMD ”), an innovative health services company transforming the delivery of care, is [...]
Tarsus to Participate in Upcoming Investor Conferences
29/05/2024
IRVINE, Calif., May 29, 2024 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients [...]
Reviva Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
29/05/2024
CUPERTINO, Calif., May 29, 2024 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet [...]
Jasper Therapeutics to Present at the Jefferies Global Healthcare Conference
29/05/2024
REDWOOD CITY, Calif., May 29, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a biotechnology company focused on development of briquilimab, a novel antibody therapy targeting c-Kit (CD117) [...]
X4 Pharmaceuticals to Host Virtual Investor Event on June 27, 2024 to Review New Mavorixafor Clinical Data from Ongoing Phase 2 Trial in Chronic Neutropenia
29/05/2024
Webcast to include interim hematological results from at least 15 trial participants and feature experts in the treatment of chronic neutropenia BOSTON, May 29, 2024 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR [...]
ANI Pharmaceuticals to Present at the 2024 Jefferies Global Healthcare Conference
29/05/2024
BAUDETTE, Minn., May 29, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, will present at the 2024 Jefferies Global [...]
L’ Assemblée Générale Mixte de Cellectis se tiendra le 28 juin 2024
29/05/2024
NEW YORK, 29 mai 2024 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS - Nasdaq: CLLS), société de biotechnologie de stade clinique qui utilise sa technologie pionnière d’édition du génome TALEN® pour développer [...]
ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences
29/05/2024
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, May 29, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of [...]
Cellectis’ Annual Shareholders General Meeting to be Held on June 28, 2024
29/05/2024
NEW YORK, May 29, 2024 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell [...]
Sienna Senior Living Inc. Announces Results From Annual and Special Meeting
29/05/2024
MARKHAM, Ontario, May 29, 2024 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA) is pleased to announce that it has received shareholder approval in respect of all resolutions to [...]
Certara to Participate in the Jefferies Global Healthcare Conference
29/05/2024
RADNOR, Pa., May 29, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that Company management will participate in the Jefferies Global Healthcare Conference. [...]
Enlivex Therapeutics Closes up to $15 Million Registered Direct Offering
29/05/2024
Nes-Ziona, Israel, May 29, 2024 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced the closing of its previously [...]
Participation de Merus à un échange informel à l’occasion de la conférence Jefferies Global Healthcare
29/05/2024
UTRECHT, Pays-Bas et CAMBRIDGE, État du Massachusetts, 29 mai 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq : MRUS), une société d’oncologie au stade clinique développant des anticorps pleine longueur multispécifiques et [...]
GENFIT to Present Latest ACLF Research at EASL Congress™ 2024
29/05/2024
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), May 29, 2024 - GENFIT (Nasdaq and Euronext: GNFT) , a late-stage biopharmaceutical company dedicated to improving the lives of patients [...]

Pages